Rheumaderm pp 207-214 | Cite as

Psoriatic Arthritis

Is Something Changing?
  • Rafael Scarpa
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)


The definition of psoriatic arthritis may be at least inadequate. Moreover, diagnostic criteria proposed may be too restrictive. This may have affected the collection of reliable epidemiological data and may also influenced the classification of the disease. In this article all these aspects are discussed with the aim of offering an up-date on this intriguing disease. Therapeutic options are also examined.


Tiaprofenic Acid Psoriatic Patient Gold Salt Axial Pattern Nail Psoriasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Blumberg B. S., Bunim J, Calkins E, et al. Nomenclature and classification of arthritis and rheumatism (tentative) accepted by the American Rheumatism Association. Bull. Rheum. Dis.; 14: 3391–6. 1964Google Scholar
  2. 2.
    Hench P. S. Arthropathia Psoriasica-presentation of a case. Proc. Mayo Clinic, 20: 256–9. 1927Google Scholar
  3. 3.
    Fawcett J. Bone and joint changes associated with psoriasis. Brit. J. of Radiol., 23, 440–7. 1950CrossRefGoogle Scholar
  4. 4.
    Pillsbury D. M, Shelley W. B. and Kligman A. M. in Dermatology, Philadelphia, Saunders, 728–729. 1956Google Scholar
  5. 5.
    Wright V. Psoriasis and arthritis Ann. Rheum. Dis.; 15, 348–352. 1956CrossRefGoogle Scholar
  6. 6.
    Moll J. M. H, Wright V, Familial occurrence of psoriatic arthritis Ann. Rheum. Dis.; 32: 181–201. 1973CrossRefGoogle Scholar
  7. 7.
    Gladman D. D. Natural history of psoriatic arthritis in Psoriatic Arthritis Wright V and Helliwell P (Eds), Balliere’s Clinical Rheumatology, 8, number 2, 379–394. 1994Google Scholar
  8. 8.
    Scarpa R, Oriente P, Pucino A et al. Psoriatic arthritis in psoriatic patients Br. J. Rheumatol.;23: 246–250. 1984PubMedCrossRefGoogle Scholar
  9. 9.
    Scarpa R, Oriente P, Pucino A et al. The clinical spectrum of psoriatic spondylitis Br. J. Rheumatol.;27: 133–7. 1988CrossRefGoogle Scholar
  10. 10.
    Torre Alonso J. C, Rodriguez Perez A, Arribas Castrillo J.M et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients Br.J. Rheumatol.; 30: 245–250. 1991CrossRefGoogle Scholar
  11. 11.
    Helliwell P, Marchesoni A, Peters M et al. A re-evaluation of the osteoarticular manifestations of psoriasis Br. J. Rheumatol.;30: 339–45. 1991CrossRefGoogle Scholar
  12. 12.
    Scarpa R, Pucino A, Iocco M et al. The management of 138 psoriatic arthritic patients Acta Derm. Venereol. Suppl. (Stockh); 146: 199–200. 1989Google Scholar
  13. 13.
    Boffa M. U., Smith A, Chalmers R. J. G. et al Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients Br. J. Dermatol.; 135: 538–544. 1996CrossRefGoogle Scholar
  14. 14.
    Grossman R. M, Chevret S, Abi-Rached J et al Long-term safety of cyclosporin in the treatment of psoriasis Arch. Dermatol.; 132: 623–29. 1966Google Scholar
  15. 15.
    Dougados M, van der Linden S, Lerisalo-Repo M et al Sulfasalazine in the treatment of spondyloarthropathy: a randomized, multicenter, double-blind, placebo-controlled study Arthritiskheum.;38. 618–627. 1995Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Rafael Scarpa
    • 1
  1. 1.Department of Internal MedicineRheumatology Research Unit, University Federico IINaplesItaly

Personalised recommendations